ADHD - HealthQuill

Artificial intelligence platforms for psychiatric patients are showing a pattern of racial bias by proposing different treatments for people of colour, a small Cedars-Sinai study finds.

AI platforms for psychiatric patients show racial bias: Cedars-Sinai

HQ Team July 17, 2025: Artificial intelligence platforms for psychiatric patients are showing a pattern of racial bias by proposing different treatments for.

by HealthQuill
July 17, 2025
0 Comments

A majority of clinical research on adult Attention Deficit Hyperactivity Disorder (ADHD) suffers from serious methodological shortcomings, making it difficult to use the results in practice, according to researchers from the University of Copenhagen and the University of São Paulo.

Drugs Health Research

Researchers find serious flaws in clinical trials with adult ADHD patients

HQ Team July 2, 2025: A majority of clinical research on adult Attention Deficit Hyperactivity Disorder (ADHD) suffers from serious methodological shortcomings, making.

by HealthQuill
July 2, 2025
0 Comments

Excessive levels of parental involvement and control stem from a worry that their child may come to harm or not do well enough.

Health Research

Rising childhood mental health issues linked to caregiver well-being

HQ Team February 18, 2025: A new study from Florida Atlantic University’s Schmidt College of Medicine reveals a troubling rise in childhood mental,.

by HealthQuill
February 18, 2025
0 Comments

US adults with attention deficit hyperactivity disorder (ADHD) rose from 10.6% to 15.2% between 2020 and 2023, and Covid-19 pandemic may be a major factor, according to a study published in Psychiatric Research and Clinical Practice.

Health Medical Research

ADHD in US adults rises to 15.2% between 2020 and 2023: Research

US adults with attention deficit hyperactivity disorder (ADHD) rose from 10.6% to 15.2% between 2020 and 2023, and Covid-19 pandemic may be a.

by HealthQuill
January 22, 2025
0 Comments

Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression after five years, according to company data.

Health Uncategorized

Review finds links between allergic diseases and mental health conditions

HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive.

by HealthQuill
November 15, 2024
0 Comments

Drugs Health Pharma

High doses of ADHD drugs linked to increased risk of psychosis

HQ Team September 14, 2024: High doses of Attention Deficit and Hyperactivity Disorder (ADHD) medicines can lead to a greater risk of developing.

by HealthQuill
September 14, 2024
0 Comments

Drugs Health Opinion Pharma

Opinion: Proxy parenting not ideal, leads to depression, anxiety in children

The phrase "It takes a village to raise a child" emphasizes the importance of children interacting with diverse individuals beyond their immediate family..

by HealthQuill
September 12, 2024
0 Comments

Drugs Health Pharma

Energy drinks linked to ADHD, anxiety among youth: Study

HQ Team January 20, 2024: Energy drinks have become increasingly popular among teenagers, with over 30% of teens aged 12–17 regularly consuming these.

by HealthQuill
January 20, 2024
10 Comments

Takeda Pharmaceutical’s subsidiary, Shire Plc., was granted an FDA nod for making generic chewable tablets to treat attention-deficit, hyperactivity disorder, and moderate to severe binge disorder in adults.

Drugs Health Pharma

First generic versions of Japan’s Takeda ADHD tabs gets FDA nod

HQ Team August 29, 2023: The US Food and Drug Administration has approved several first generics of Takeda Pharmaceutical subsidiary, Shire Plc’s Vyvanse.